These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6434499)

  • 21. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous intravenous administration of 1-(2-tetrahydrofuryl)-5-fluorouracil [FT] by intravenous hyperalimentation (IVH)--stability of FT in IVH solution and tumor levels of 5-fluorouracil (5-FU).
    Moriya Y; Koyama Y; Hojo K; Tsunematsu R
    Jpn J Clin Oncol; 1983 Mar; 13(1):31-5. PubMed ID: 6403740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo 19F NMR comparative study of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and an FT-uracil coadministration system in mouse tumors.
    Kanazawa Y; Kurogi S; Shinohara S; Noda Y; Masuda K
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):774-8. PubMed ID: 8020119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
    Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT].
    Koida T; Kimura M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1147-51. PubMed ID: 3922313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
    Ohyama K; Koike D; Odake Y; Takiyama Y; Saitoh T; Kagaya T; Takebe T; Ishii K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2168-74. PubMed ID: 6307180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology of combined oral uracil and ftorafur.
    Ho DH; Covington WP; Pazdur R; Brown NS; Kuritani J; Newman RA; Raber MN; Krakoff IH
    Drug Metab Dispos; 1992; 20(6):936-40. PubMed ID: 1362949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of the pharmacology of oral tegafur to its use as a 5-FU pro-drug.
    Byfield JE; Hornbeck CL; Frankel SS; Sharp TR; Griffiths JC
    Cancer Treat Rep; 1985 Jun; 69(6):645-52. PubMed ID: 3926308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels.
    Miyauchi S; Imaoka T; Utsunomiya T; Hayashi K; Kubo M; Kawaguchi T; Matsui Y
    Jpn J Cancer Res; 1994 Jun; 85(6):665-8. PubMed ID: 8063621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
    Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):422-8. PubMed ID: 3131462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction].
    Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):640-7. PubMed ID: 2141051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
    Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Nemoto A; Yamamoto H; Asagoe T; Takada T; Yasuda H; Shikata J
    Cancer; 1987 May; 59(9):1571-6. PubMed ID: 3103905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
    Wu AT; Au JL; Sadée W
    Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma.
    Queisser W; Schnitzler G; Schaefer J; Arnold H; Drings P; Fritze D; Geldmacher J; Hartwich G; Herrmann R; Kempf P; König H; Meiser RJ; Nedden R; von Oldershausen HF; Pappas A; Sievers H; Wahrendorf J; Westerhausen M; Witte S
    Recent Results Cancer Res; 1981; 79():82-92. PubMed ID: 6795701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing cell kinetic studies of the effect of ftorafur and 5-fluorouracil on the L 1210 ascites tumor.
    Schultze B; Jellinghaus W; Weis G; Müller V; Maurer W
    J Cancer Res Clin Oncol; 1981; 100(1):25-40. PubMed ID: 6787060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.